Revati Shreeniwas
President at Revati, Inc.
Profile
Revati Shreeniwas is currently the President of Revati, Inc. and a Member of Continuing Medical Education, Inc. She previously worked as a Principal at Scios, Inc. and CV Therapeutics, Inc., as well as the Vice President of Clinical Research & Development at Alvine Pharmaceuticals, Inc. She also held the position of Principal at The Trustees of Columbia University in The City of New York and was a Professor at Stanford University.
Additionally, she served as the Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017 and is currently the Chief Medical Officer at Bright Minds Biosciences, Inc. from 2020 to 2022.
Revati Shreeniwas active positions
| Companies | Position | Start |
|---|---|---|
Continuing Medical Education, Inc.
 Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Part of Elliott International Advisors GP LLC, Continuing Medical Education, Inc. publishes medical magazines and journals. The company is based in San Diego, CA. Continuing Medical Education was acquired by Miller Freeman, Inc., part of Elliott International Advisors GP LLC from July 18, 2000 on March 26, 1999 for $111 million. | Corporate Officer/Principal | - |
| Revati, Inc. | President | 01/01/2004 |
Former positions of Revati Shreeniwas
| Companies | Position | End |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Chief Tech/Sci/R&D Officer | 01/12/2022 |
| SOLENO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/06/2020 |
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
| Stanford University | Corporate Officer/Principal | - |
| The Trustees of Columbia University in The City of New York | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| SOLENO THERAPEUTICS, INC. | Health Technology |
| BRIGHT MINDS BIOSCIENCES INC. | Health Technology |
| Private companies | 6 |
|---|---|
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
| Revati, Inc. | |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Health Technology |
Continuing Medical Education, Inc.
Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Part of Elliott International Advisors GP LLC, Continuing Medical Education, Inc. publishes medical magazines and journals. The company is based in San Diego, CA. Continuing Medical Education was acquired by Miller Freeman, Inc., part of Elliott International Advisors GP LLC from July 18, 2000 on March 26, 1999 for $111 million. | Consumer Services |
NeurAxon Pharma, Inc.
NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services NeurAxon Pharma, Inc. researches and develops nervous system disorder therapies. The company is headquartered in Mississauga, Canada. | Commercial Services |
- Stock Market
- Insiders
- Revati Shreeniwas
